(Q44015814)

29 November 2017

Itraconazole- and fluconazole-induced toxicity in rat hepatocytes: a comparative in vitro study (English)

1 reference

29 November 2017

N Somchit

1

1 reference

PubMed ID

12046723

29 November 2017

S M Hassim

series ordinal

2

1 reference

PubMed ID

12046723

29 November 2017

S H Samsudin

series ordinal

3

1 reference

29 November 2017

1 January 2002

1 reference

Human & Experimental Toxicology

29 November 2017

1 reference

29 November 2017

21

1 reference

29 November 2017

1

1 reference

29 November 2017

43-48

1 reference

Azole antifungal agents: emphasis on new triazoles

29 November 2017

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Antifungal agents. Part II. The azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Hepatic injury associated with itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Adverse events associated with itraconazole in 189 patients on chronic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Oral azole drugs as systemic antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Influence of modulators of epoxide metabolism on the cytotoxicity of trans-anethole in freshly isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

The maintenance of cytochrome P-450 in rat hepatocyte culture: some applications of liver cell cultures to the study of drug metabolism, toxicity and the induction of the P-450 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

P450 genes: structure, evolution, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0960327102HT208OA

10.1191/0960327102HT208OA

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12046723